HBV and HCV Therapy

By Lampertico Pietro   Aghemo Alessio   Viganò Mauro   Colombo Massimo  

Viruses, Vol. 1, Iss. 3, 2009-10 ,pp. : 484-509

MDPI

Access to resources Recommend Favorite

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors

By Kanda Tatsuo   Yasui Shin   Nakamura Masato   Suzuki Eiichiro   Arai Makoto   Ooka Yoshihiko   Ogasawara Sadahisa   Chiba Tetsuhiro   Saito Tomoko   Haga Yuki   Takahashi Koji   Sasaki Reina   Wu Shuang   Nakamoto Shingo   Tawada Akinobu   Maruyama Hitoshi   Imazeki Fumio   Kato Naoya   Yokosuka Osamu  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 906-906

MDPI

Access to resources Recommend Favorite

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy

By D’Ambrosio Roberta   Della Corte Cristina   Colombo Massimo  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 19698-19712

MDPI

Access to resources Recommend Favorite

Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian Patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 3, 2015-03 ,pp. : 428-440

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progress and Prospects of Anti-HBV Gene Therapy Development

By Maepa Mohube B.   Roelofse Ilke   Ely Abdullah   Arbuthnot Patrick  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-07 ,pp. : 17589-17610

MDPI

Access to resources Recommend Favorite